趨勢與洞察

作者: Austin Chuang 2026 Apr 10
Master the regulatory framework, essential qualifications, and organizational duties for a Good Distribution Practice (GDP) Responsible Person.
作者: Austin Chuang 2026 Apr 10
A comprehensive guide to maintaining pharmaceutical supply chain integrity, regulatory compliance, and robust quality management systems.
作者: Austin Chuang 2026 Apr 10
Navigate European and international GMP regulations for biotechnological products, focusing on process control, virus safety, and inherent variability.
作者: Austin Chuang 2026 Apr 10
Explore the mechanisms of stainless steel oxidation, rouging classifications, and actionable lifecycle management strategies to ensure GMP compliance in your pharmaceutical facility.
作者: Austin Chuang 2026 Apr 10
Prepare for the EMA's new 3-year work plan including updates to Annex 15, Annex 22, and key GMP chapters.
作者: Austin Chuang 2026 Apr 10
An in-depth analysis of Simtra BioPharma's CGMP violations, highlighting risks from equipment dead legs, failed CAPA, and systemic contamination.
作者: Austin Chuang 2026 Apr 10
Discover key GMP violations from the recent FDA Warning Letter to OraLabs Inc. Learn why rigorous Root Cause Analysis is critical for compliance.
作者: Austin Chuang 2026 Apr 10
An Indian lab faces FDA action for systemic data destruction, backdated records, and inspection obstruction. See how this impacts CGMP compliance.
作者: Austin Chuang 2026 Apr 10
Navigate the regulatory shift towards patient-centric quality attributes for autologous cell and gene therapies with expert insights.
作者: Austin Chuang 2026 Apr 10
How ignored Performance Qualification (PQ) failures and systemic dead legs in pharmaceutical water systems led to an FDA Warning Letter.